Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery. - Wikidata - wikimedia - TriplyDB

Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.

Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.

http://www.wikidata.org/entity/Q37335477

about

Intranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunity Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.

P2860

Q33708572-4F614C50-CBE7-4A88-AAE0-6F03DB717526 Q35498252-01AE9E33-2172-4044-9279-0FE9272E0AA9 Q36978334-B3528CF4-09C6-40C5-8C31-BDEB89712BCC

P2860

Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery.

http://www.wikidata.org/entity/Q37335477

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Enhancement of serum and mucos ...... accine by intranasal delivery.

@en

Enhancement of serum and mucos ...... accine by intranasal delivery.

@nl

type

label

Enhancement of serum and mucos ...... accine by intranasal delivery.

@en

Enhancement of serum and mucos ...... accine by intranasal delivery.

@nl

prefLabel

Enhancement of serum and mucos ...... accine by intranasal delivery.

@en

Enhancement of serum and mucos ...... accine by intranasal delivery.

@nl

P1433

Q37335477-324D5850-4A10-43A6-9439-E016FB56B4AE

P1476

Q37335477-15FB6F19-9247-484C-A48C-220B456EB055

P2093

Q37335477-053A60AD-AA28-4956-90D1-6895FCBA8360

Q37335477-600CC421-7135-4DF6-9F0D-3DDFF8F46A6C

Q37335477-E656E9A6-CAD1-48C6-8292-FDAE28550BA9

P2860

Q37335477-1591B1CA-9C98-4339-9A2E-3D258A54889E

Q37335477-1FDA5B6B-C7D9-4670-B43B-C86F6AAF5886

Q37335477-2919020D-A1A1-46A1-9BC8-8BD7062EAEAB

Q37335477-32B5814C-B924-456B-91F3-0D4BF52BBA81

Q37335477-350B3FB2-3040-47AB-A0E1-2720DABAE07E

Q37335477-3D472788-D300-4A7D-A2D4-B7A8791E4A38

Q37335477-3D51031C-32A5-465E-BDEB-169A4DE64BD9

Q37335477-4402A734-B098-4450-BBE0-B26D4E8B76E0

Q37335477-48485943-5AE6-49C8-81DF-51D04178F79D

Q37335477-55BFBBA1-37BF-4475-97E2-7BA8F4A2EFE2

P304

Q37335477-4BECF731-12A0-4F1F-89D2-34E3F395F98E

P31

Q37335477-E5F1F449-944F-4271-B688-CA1465191F49

P356

Q37335477-C8295EE6-CE72-44CB-8BF0-EDDEC53654A6

P433

Q37335477-4DDFC988-53D5-4B10-BA87-81AAE60CEABC

P478

Q37335477-862D93F8-B365-4B3C-AAFF-79A209465FED

P577

Q37335477-74DEE78D-5002-479C-90D6-BC74CD0EF4CA

P698

Q37335477-C4B626A0-F95B-481E-83FB-749D5053E8A1

P932

Q37335477-1CE3B306-2AF2-46C6-B36D-120F18ED8E98

P356

P1433

Clinical and Vaccine Immunology

P1476

Enhancement of serum and mucos ...... accine by intranasal delivery.

@en

P2093

Emily D Cisney

http://www.w3.org/2001/XMLSchema#string

Robert G Ulrich

http://www.w3.org/2001/XMLSchema#string

Stefan Fernandez

http://www.w3.org/2001/XMLSchema#string

P2860

Thymus-Independent and Thymus-Dependent Responses to Polysaccharide Antigens

Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.

Regional specialization in the mucosal immune system: what happens in the microcompartments?

Regional specialization in the mucosal immune system: primed cells do not always home along the same track.

Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines.

Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.

M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses

Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines.

NALT- versus Peyer's-patch-mediated mucosal immunity.

Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.

P304

1690-1696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00215-13

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23986319

http://www.w3.org/2001/XMLSchema#string

P932

3837783

http://www.w3.org/2001/XMLSchema#string